Sandra Hirschberg

Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men

Ulf Risérus, Dennis L. Sprecher, Tony G. Johnson et al. · Diabetes · 2007 · 319 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours.

Sarah Halford, Paul S. Jones, Sandra Hirschberg et al. · Journal of Clinical Oncology · 2017 · 55 citations

Medicine, Oncology, Pharmacology +14

A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours

Ruth Plummer, Sarah Halford, Paul S. Jones et al. · Annals of Oncology · 2018 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +7